LabCorp
LH
#1100
Rank
NZ$37.00 B
Marketcap
NZ$449.10
Share price
-3.19%
Change (1 day)
22.04%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2025 (TTM): NZ$18.03

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$17.92. an increase over its 2024 EPS that were of NZ$15.13.

EPS history for LabCorp from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$17.8017.66%
2024NZ$15.1389.15%
2023NZ$8.00-66.26%
2022NZ$23.70-43.33%
2021NZ$41.8354.11%
2020NZ$27.1489.43%
2019NZ$14.33-3.33%
2018NZ$14.82-29.7%
2017NZ$21.0875.74%
2016NZ$12.0063.19%
2015NZ$7.35-28.4%
2014NZ$10.27-6.13%
2013NZ$10.945.2%
2012NZ$10.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$22.43 25.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.09-15.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.50-108.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.51-80.44%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.36-101.99%๐Ÿ‡บ๐Ÿ‡ธ USA